Global Platform Advantage Taconic's global footprint and end-to-end model services enable winning large multinational preclinical programs and rapid model delivery across the US, Europe, and Asia.

CRISPR Leadership Exclusive Helmholtz Munich license for advanced CRISPR gene editing and the ExpressMODEL CRISPR platform, plus a Cyagen collaboration, position Taconic to provide expanded gene-edited model libraries and rapid customization for customers.

Immuno-Disease Focus FcResolv NOG immunodeficient mice launch coupled with disease-focused partnerships for ultra-rare disorders signals strong demand for specialized disease models and immunology platforms to accelerate preclinical studies.

Strategic Partnerships Active collaborations with Cyagen to access large model catalogs and exclusive licensing with Helmholtz Munich offer channels to reach larger customer groups and expand offerings across geographies.

Scale and Value A sizable global operation with integrated model design, breeding services and multi-lab presence positions Taconic to win large pharma and CRO engagements seeking end-to-end, compliant preclinical model solutions.